111 related articles for article (PubMed ID: 26159559)
1. "Reuse" study of low-tube-voltage CT arterial phase in the spoiled gadoxetic-acid liver MRI.
Ku MC; Lee CH; Park YS; Lee J; Choi JW; Kim KA; Park CM
Clin Imaging; 2015; 39(5):820-6. PubMed ID: 26159559
[TBL] [Abstract][Full Text] [Related]
2. Detection of hepatocellular carcinoma: gadoxetic acid-enhanced 3-dimensional magnetic resonance imaging versus multi-detector row computed tomography.
Kim YK; Kim CS; Han YM; Kwak HS; Jin GY; Hwang SB; Chung GH; Lee SY; Yu HC
J Comput Assist Tomogr; 2009; 33(6):844-50. PubMed ID: 19940648
[TBL] [Abstract][Full Text] [Related]
3. Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma.
Kim SH; Kim SH; Lee J; Kim MJ; Jeon YH; Park Y; Choi D; Lee WJ; Lim HK
AJR Am J Roentgenol; 2009 Jun; 192(6):1675-81. PubMed ID: 19457834
[TBL] [Abstract][Full Text] [Related]
4. Detection of small hepatocellular carcinoma: can gadoxetic acid-enhanced magnetic resonance imaging replace combining gadopentetate dimeglumine-enhanced and superparamagnetic iron oxide-enhanced magnetic resonance imaging?
Kim YK; Kim CS; Han YM; Park G
Invest Radiol; 2010 Nov; 45(11):740-6. PubMed ID: 20644488
[TBL] [Abstract][Full Text] [Related]
5. Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging.
Sun HY; Lee JM; Shin CI; Lee DH; Moon SK; Kim KW; Han JK; Choi BI
Invest Radiol; 2010 Feb; 45(2):96-103. PubMed ID: 20057319
[TBL] [Abstract][Full Text] [Related]
6. Detectability of hepatocellular carcinoma on gadoxetic acid-enhanced MRI at 3 T in patients with severe liver dysfunction: clinical impact of dual-source parallel radiofrequency excitation.
Nishie A; Kakihara D; Asayama Y; Ushijima Y; Takayama Y; Fujita N; Shimamoto D; Shirabe K; Hida T; Honda H
Clin Radiol; 2015 Mar; 70(3):254-61. PubMed ID: 25522901
[TBL] [Abstract][Full Text] [Related]
7. Using low tube voltage (80kVp) quadruple phase liver CT for the detection of hepatocellular carcinoma: two-year experience and comparison with Gd-EOB-DTPA enhanced liver MRI.
Lee CH; Kim KA; Lee J; Park YS; Choi JW; Park CM
Eur J Radiol; 2012 Apr; 81(4):e605-11. PubMed ID: 22297180
[TBL] [Abstract][Full Text] [Related]
8. Performance of gadoxetic acid-enhanced MRI for detecting hepatocellular carcinoma in recipients of living-related-liver-transplantation: comparison with dynamic multidetector row computed tomography and angiography-assisted computed tomography.
Kakihara D; Nishie A; Harada N; Shirabe K; Tajima T; Asayama Y; Ishigami K; Nakayama T; Takayama Y; Okamoto D; Fujita N; Kishimoto J; Honda H
J Magn Reson Imaging; 2014 Nov; 40(5):1112-20. PubMed ID: 24259437
[TBL] [Abstract][Full Text] [Related]
9. Role of C-arm CT for transcatheter arterial chemoembolization of hepatocellular carcinoma: diagnostic performance and predictive value for therapeutic response compared with gadoxetic acid-enhanced MRI.
Yu MH; Kim JH; Yoon JH; Kim HC; Chung JW; Han JK; Choi BI
AJR Am J Roentgenol; 2013 Sep; 201(3):675-83. PubMed ID: 23971463
[TBL] [Abstract][Full Text] [Related]
10. Ferucarbotran-enhanced magnetic resonance imaging versus gadoxetic acid-enhanced magnetic resonance imaging for the preoperative detection of hepatocellular carcinoma: initial experience.
Lee JY; Kim SH; Jeon YH; Lee J; Kim MJ; Choi D; Lee WJ
J Comput Assist Tomogr; 2010 Jan; 34(1):127-34. PubMed ID: 20118735
[TBL] [Abstract][Full Text] [Related]
11. Gadoxetic acid-enhanced MRI compared with CT during angiography in the diagnosis of hepatocellular carcinoma.
Ooka Y; Kanai F; Okabe S; Ueda T; Shimofusa R; Ogasawara S; Chiba T; Sato Y; Yoshikawa M; Yokosuka O
Magn Reson Imaging; 2013 Jun; 31(5):748-54. PubMed ID: 23218794
[TBL] [Abstract][Full Text] [Related]
12. Detection of liver malignancy with gadoxetic acid-enhanced MRI: is addition of diffusion-weighted MRI beneficial?
Kim YK; Kim CS; Han YM; Lee YH
Clin Radiol; 2011 Jun; 66(6):489-96. PubMed ID: 21367403
[TBL] [Abstract][Full Text] [Related]
13. Comparison of gadoxetic acid-enhanced MRI and superparamagnetic iron oxide-enhanced MRI for the detection of hepatocellular carcinoma.
Kim YK; Kim CS; Han YM; Park G; Hwang SB; Yu HC
Clin Radiol; 2010 May; 65(5):358-65. PubMed ID: 20380933
[TBL] [Abstract][Full Text] [Related]
14. Comparison of gadoxetic acid-enhanced magnetic resonance imaging and contrast-enhanced computed tomography with histopathological examinations for the identification of hepatocellular carcinoma: a multicenter phase III study.
Tsurusaki M; Sofue K; Isoda H; Okada M; Kitajima K; Murakami T
J Gastroenterol; 2016 Jan; 51(1):71-9. PubMed ID: 26130441
[TBL] [Abstract][Full Text] [Related]
15. Detection of hepatocellular carcinoma in gadoxetic acid-enhanced MRI and diffusion-weighted MRI with respect to the severity of liver cirrhosis.
Kim AY; Kim YK; Lee MW; Park MJ; Hwang J; Lee MH; Lee JW
Acta Radiol; 2012 Oct; 53(8):830-8. PubMed ID: 22847903
[TBL] [Abstract][Full Text] [Related]
16. Comparison of gadoxetic acid-enhanced MR imaging versus four-phase multi-detector row computed tomography in assessing tumor regression after radiofrequency ablation in subjects with hepatocellular carcinomas.
Yoon JH; Lee EJ; Cha SS; Han SS; Choi SJ; Juhn JR; Kim MH; Lee YJ; Park SJ
J Vasc Interv Radiol; 2010 Mar; 21(3):348-56. PubMed ID: 20116285
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic performance of gadoxetic acid (Primovist)-enhanced MR imaging versus CT during hepatic arteriography and portography for small hypervascular hepatocellular carcinoma.
Yim SY; Park BJ; Um SH; Han NY; Sung DJ; Cho SB; Lee SH; Kim MJ; Jung JY; Kim JD; Seo YS; Kim DS; An H; Kim YH
Medicine (Baltimore); 2016 Sep; 95(39):e4903. PubMed ID: 27684824
[TBL] [Abstract][Full Text] [Related]
18. Imaging study of early hepatocellular carcinoma: usefulness of gadoxetic acid-enhanced MR imaging.
Sano K; Ichikawa T; Motosugi U; Sou H; Muhi AM; Matsuda M; Nakano M; Sakamoto M; Nakazawa T; Asakawa M; Fujii H; Kitamura T; Enomoto N; Araki T
Radiology; 2011 Dec; 261(3):834-44. PubMed ID: 21998047
[TBL] [Abstract][Full Text] [Related]
19. Detection of small hepatocellular carcinoma using gadoxetic acid-enhanced MRI: Is the addition of diffusion-weighted MRI at 3.0T beneficial?
Zhao XT; Li WX; Chai WM; Chen KM
J Dig Dis; 2014 Mar; 15(3):137-45. PubMed ID: 24354621
[TBL] [Abstract][Full Text] [Related]
20. Small (≤ 2 cm) hepatocellular carcinoma in patients with chronic liver disease: comparison of gadoxetic acid-enhanced 3.0 T MRI and multiphasic 64-multirow detector CT.
Hwang J; Kim SH; Lee MW; Lee JY
Br J Radiol; 2012 Jul; 85(1015):e314-22. PubMed ID: 22167508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
